Cutaneous sporotrichoid leishmaniasis treated with oral fluconazole

Dermatol Ther. 2019 Jul;32(4):e12976. doi: 10.1111/dth.12976. Epub 2019 Jun 17.

Authors

Michael Benzaquen¹, Audrey Chambelland¹, Jessica Fongue¹, Cléa Melenotte², Jacques-Robert Christen², Stéphane Ranque², Jean-Pascal Buono³, Philippe Parola², Philippe Berbis¹

Affiliations

¹ Aix Marseille University, APHM, Hôpital Nord, Department of Dermatology, Marseille, France.
² Aix Marseille University, IRD, APHM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France.
³ Aix Marseille University, APHM, Hôpital Nord, Department of Anatomical and Cellular Pathology, Marseille, France.

PMID: 31150139
DOI: 10.1111/dth.12976

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Oral
Aged
Antifungal Agents / administration & dosage
Fluconazole / administration & dosage*
Humans
Leishmania / isolation & purification*
Leishmaniasis, Cutaneous / diagnosis
Leishmaniasis, Cutaneous / drug therapy*
Leishmaniasis, Cutaneous / parasitology
Male

Substances

Antifungal Agents
Fluconazole